Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting

ClinicalTrials.gov ID: NCT02004262

Public ClinicalTrials.gov record NCT02004262. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 7:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2B, Randomized, Controlled, Multicenter, Open-Label Study of the Efficacy and Immune Response of GVAX Pancreas Vaccine (With Cyclophosphamide) and CRS 207 Compared to Chemotherapy or to CRS-207 Alone in Adults With Previously-Treated Metastatic Pancreatic Adenocarcinoma

Study identification

NCT ID
NCT02004262
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Aduro Biotech, Inc.
Industry
Enrollment
303 participants

Conditions and interventions

Interventions

  • CRS-207 Biological
  • Chemotherapy Drug
  • GVAX Pancreas Vaccine Biological
  • cyclophosphamide Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 4, 2014
Primary completion
Dec 31, 2015
Completion
Aug 22, 2016
Last update posted
Jun 3, 2018

2014 – 2016

United States locations

U.S. sites
20
U.S. states
17
U.S. cities
19
Facility City State ZIP Site status
Scottsdale Healthcare Research Institute Scottsdale Arizona 85258
University California San Diego Moores Cancer Center La Jolla California 92037
University of California Mt Zion Comprehensive Cancer Center San Francisco California 94115
University of California Los Angeles Santa Monica California 90404
University of Colorado Denver Aurora Colorado 80045
University of Miami/Sylvester Cancer Center Miami Florida 33136
University of Chicago Medical Center Chicago Illinois 60637
Johns Hopkins University Baltimore Maryland 21287
Mayo Clinic Rochester Rochester Minnesota 55905
Washington University St Louis Missouri 63110
Icahn School of Medicine at Mount Sinai New York New York 10029
Columbia University Medical Center New York New York 10032
Duke University Medical Center Morris Cancer Center Durham North Carolina 27710
Providence Cancer Center Portland Oregon 97213
University of Pittsburgh Medical Center Cancer Pavillion Pittsburgh Pennsylvania 15232
Vanderbilt University Nashville Tennessee 37215
Baylor College of Medicine Houston Texas 77030
University of Virginia Health System Charlottesville Virginia 22908
Virginia Mason Medical Center Seattle Washington 98101
University of Wisconsin - Carbone Cancer Center Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02004262, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 3, 2018 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02004262 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →